“…One mechanism of potential significance is the ability of fl-adrenoceptor agonists (and other agents which increase cyclic AMP levels) to inhibit Hist-stimulated inositol phospholipid hydrolysis (Hall & Hill, 1988;Madison & Brown, 1988;Hall et al, 1989). These initial reports hypothesized that inhibition of inositol phospholipid turnover might be extrapolated to infer an effect on the concentration of inositol 1,4,5-trisphosphate, a second messenger generally acknowledged to be responsible for the initiation of pharmacomechanical coupling in airways smooth muscle (Chilvers et al, 1994a). Although more recent studies have not supported this idea (see Challiss et al, 1993), it is likely that the ability of f,-adrenoceptor agonists to inhibit a spasmogen-stimulated signal transduction pathway will contribute, to a greater or lesser degree, to the relaxant activity of these agents.…”